| Lixisenatide in patients with type 2 diabetes and acute coronary syndrome MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Køber, ... New England Journal of Medicine 373 (23), 2247-2257, 2015 | 1686 | 2015 |
| Spironolactone for heart failure with preserved ejection fraction B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ... N Engl J Med 370, 1383-1392, 2014 | 1571 | 2014 |
| Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial MA Pfeffer, B Claggett, SF Assmann, R Boineau, IS Anand, N Clausell, ... Circulation 131 (1), 34-42, 2015 | 592 | 2015 |
| Impaired systolic function by strain imaging in heart failure with preserved ejection fraction E Kraigher-Krainer, AM Shah, DK Gupta, A Santos, B Claggett, B Pieske, ... Journal of the American College of Cardiology 63 (5), 447-456, 2014 | 520 | 2014 |
| Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... New England Journal of Medicine 381 (17), 1609-1620, 2019 | 489 | 2019 |
| Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis H Uno, B Claggett, L Tian, E Inoue, P Gallo, T Miyata, D Schrag, ... Journal of clinical Oncology 32 (22), 2380, 2014 | 357 | 2014 |
| Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis SB Seidelmann, B Claggett, S Cheng, M Henglin, A Shah, LM Steffen, ... The Lancet Public Health 3 (9), e419-e428, 2018 | 314 | 2018 |
| Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients AS Desai, JJV McMurray, M Packer, K Swedberg, JL Rouleau, F Chen, ... European heart journal 36 (30), 1990-1997, 2015 | 312 | 2015 |
| Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone AM Shah, B Claggett, NK Sweitzer, SJ Shah, IS Anand, L Liu, B Pitt, ... Circulation 132 (5), 402-414, 2015 | 264 | 2015 |
| Declining risk of sudden death in heart failure L Shen, PS Jhund, MC Petrie, BL Claggett, S Barlera, JGF Cleland, ... New England Journal of Medicine 377 (1), 41-51, 2017 | 258 | 2017 |
| Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction SD Solomon, B Claggett, EF Lewis, A Desai, I Anand, NK Sweitzer, ... European heart journal 37 (5), 455-462, 2016 | 235 | 2016 |
| Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure MR Zile, BL Claggett, MF Prescott, JJV McMurray, M Packer, JL Rouleau, ... Journal of the American College of Cardiology 68 (22), 2425-2436, 2016 | 199 | 2016 |
| Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial JP Seferovic, B Claggett, SB Seidelmann, EW Seely, M Packer, MR Zile, ... The lancet Diabetes & endocrinology 5 (5), 333-340, 2017 | 180 | 2017 |
| Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac … AM Shah, B Claggett, NK Sweitzer, SJ Shah, IS Anand, E O’Meara, ... Circulation: Heart Failure 7 (5), 740-751, 2014 | 177 | 2014 |
| Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum LH Lund, B Claggett, J Liu, CS Lam, PS Jhund, GM Rosano, K Swedberg, ... European journal of heart failure 20 (8), 1230-1239, 2018 | 169 | 2018 |
| Impaired left atrial function in heart failure with preserved ejection fraction ABS Santos, E Kraigher‐Krainer, DK Gupta, B Claggett, MR Zile, B Pieske, ... European journal of heart failure 16 (10), 1096-1103, 2014 | 159 | 2014 |
| Spironolactone metabolites in TOPCAT—new insights into regional variation S de Denus, E O’Meara, AS Desai, B Claggett, EF Lewis, G Leclair, ... The New England journal of medicine 376 (17), 1690, 2017 | 149 | 2017 |
| PARAGON-HF Investigators and Committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... N Engl J Med 381 (17), 1609-1620, 2019 | 148 | 2019 |
| Sex‐specific cardiovascular structure and function in heart failure with preserved ejection fraction M Gori, CSP Lam, DK Gupta, ABS Santos, S Cheng, AM Shah, B Claggett, ... European journal of heart failure 16 (5), 535-542, 2014 | 144 | 2014 |
| Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction AA Voors, M Gori, LCY Liu, B Claggett, MR Zile, B Pieske, JJV McMurray, ... European journal of heart failure 17 (5), 510-517, 2015 | 141 | 2015 |
Scott SolomonBrigham and Women's HospitalDirección de correo verificada de rics.bwh.harvard.edu
